Compile Data Set for Download or QSAR
maximum 50k data
Found 52 Enz. Inhib. hit(s) with all data for entry = 10020
TargetGalectin-1(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508728(5-Bromo-6-trifluoromethyl-pyridine-3-yl 3-[4-(4-ch...)
Affinity DataKd:  110nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-3(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508753(5-Chloro-N,N′-dimethyl-picolinamide-3-yl 3-d...)
Affinity DataKd:  1.70E+3nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-1(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508729(5-Bromo-6-trifluoromethyl-pyridine-3-yl 3-[4-(4-br...)
Affinity DataKd:  160nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-3(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508729(5-Bromo-6-trifluoromethyl-pyridine-3-yl 3-[4-(4-br...)
Affinity DataKd:  580nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-1(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508730(5-Chloro-6-cyano-pyridine-3-yl 3-[4-(4-chlorothiaz...)
Affinity DataKd:  95nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-3(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508730(5-Chloro-6-cyano-pyridine-3-yl 3-[4-(4-chlorothiaz...)
Affinity DataKd:  420nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-1(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508731(5-Bromo-2-cyano-pyridine-3-yl 3-[4-(4-chlorothiazo...)
Affinity DataKd:  85nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-3(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508731(5-Bromo-2-cyano-pyridine-3-yl 3-[4-(4-chlorothiazo...)
Affinity DataKd:  200nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-1(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508732(5-Chloro-2-cyano-pyridine-3-yl 3-[4-(4-chlorothiaz...)
Affinity DataKd:  95nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-3(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508732(5-Chloro-2-cyano-pyridine-3-yl 3-[4-(4-chlorothiaz...)
Affinity DataKd:  220nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-1(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508733(5-Bromo-6-cyano-3-pyridyl 3-[4-(4-chlorothiazol-2-...)
Affinity DataKd:  68nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-3(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508733(5-Bromo-6-cyano-3-pyridyl 3-[4-(4-chlorothiazol-2-...)
Affinity DataKd:  250nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-1(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508734(3,4-Dichlorophenyl 3-[4-(2-chlorothiazol-4-yl)-1H-...)
Affinity DataKd:  490nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-3(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508734(3,4-Dichlorophenyl 3-[4-(2-chlorothiazol-4-yl)-1H-...)
Affinity DataKd:  1.40E+3nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-1(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508735(3,4-Dichlorophenyl 3-deoxy-3-[4-(4-hydroxythiazol-...)
Affinity DataKd:  650nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-3(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508735(3,4-Dichlorophenyl 3-deoxy-3-[4-(4-hydroxythiazol-...)
Affinity DataKd:  1.70E+3nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-1(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508736(3,4-Dichlorophenyl 3-deoxy-3-[4-(2-hydroxythiazol-...)
Affinity DataKd:  58nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-3(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508736(3,4-Dichlorophenyl 3-deoxy-3-[4-(2-hydroxythiazol-...)
Affinity DataKd:  8.60E+3nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-1(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508737(5-Chloro-6-cyano-pyridine-3-yl 3-deoxy-3-[4-(2-hyd...)
Affinity DataKd:  38nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-3(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508737(5-Chloro-6-cyano-pyridine-3-yl 3-deoxy-3-[4-(2-hyd...)
Affinity DataKd:  8.00E+3nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-1(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508738(5-Bromo-2-cyano-pyridine-3-yl 3-deoxy-3-[4-(2-hydr...)
Affinity DataKd:  33nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-3(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508738(5-Bromo-2-cyano-pyridine-3-yl 3-deoxy-3-[4-(2-hydr...)
Affinity DataKd:  2.60E+3nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-1(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508739(5-Bromo-6-cyano-3-pyridyl 3-deoxy-3-[4-(2-hydroxyt...)
Affinity DataKd:  19nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-3(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508739(5-Bromo-6-cyano-3-pyridyl 3-deoxy-3-[4-(2-hydroxyt...)
Affinity DataKd:  2.80E+3nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-1(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508740(5-Chloro-2-cyano-3-pyridyl 3-deoxy-3-[4-(2-hydroxy...)
Affinity DataKd:  6nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-3(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508740(5-Chloro-2-cyano-3-pyridyl 3-deoxy-3-[4-(2-hydroxy...)
Affinity DataKd:  2.20E+3nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-1(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508741(5-Chloro-6-trifluoromethyl-pyridin-3-yl 3-deoxy-3-...)
Affinity DataKd:  28nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-3(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508741(5-Chloro-6-trifluoromethyl-pyridin-3-yl 3-deoxy-3-...)
Affinity DataKd:  2.80E+3nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-1(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508742(3,5-Dichloro-4-fluoro-phenyl 3-deoxy-3-[4-(2-hydro...)
Affinity DataKd:  27nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-3(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508742(3,5-Dichloro-4-fluoro-phenyl 3-deoxy-3-[4-(2-hydro...)
Affinity DataKd:  9.70E+3nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-1(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508743(3,4,5-trichlorophenyl 3-deoxy-3-[4-(2-hydroxythiaz...)
Affinity DataKd:  56nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-3(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508743(3,4,5-trichlorophenyl 3-deoxy-3-[4-(2-hydroxythiaz...)
Affinity DataKd:  6.00E+3nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-1(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508744(3,5-dibromo-4-fluorophenyl 3-deoxy-3-[4-(2-hydroxy...)
Affinity DataKd:  50nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-3(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508744(3,5-dibromo-4-fluorophenyl 3-deoxy-3-[4-(2-hydroxy...)
Affinity DataKd:  4.60E+3nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-1(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508745(3-Bromo-4-cyanophenyl 3-deoxy-3-[4-(2-hydroxythiaz...)
Affinity DataKd:  63nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-3(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508745(3-Bromo-4-cyanophenyl 3-deoxy-3-[4-(2-hydroxythiaz...)
Affinity DataKd:  6.00E+3nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-1(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508746(5-Bromo-6-trifluoromethyl-3-pyridyl 3-deoxy-3-[4-(...)
Affinity DataKd:  32nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-3(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508746(5-Bromo-6-trifluoromethyl-3-pyridyl 3-deoxy-3-[4-(...)
Affinity DataKd:  3.10E+3nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-1(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508747(3-Chloro-4-trifluoromethylphenyl 3-deoxy-3-[4-(2-h...)
Affinity DataKd:  71nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-3(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508747(3-Chloro-4-trifluoromethylphenyl 3-deoxy-3-[4-(2-h...)
Affinity DataKd:  6.50E+3nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-1(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508748(3-Chloro-4-methylphenyl 3-deoxy-3-[4-(2-hydroxythi...)
Affinity DataKd:  82nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-3(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508748(3-Chloro-4-methylphenyl 3-deoxy-3-[4-(2-hydroxythi...)
Affinity DataKd:  6.60E+3nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-1(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508749(2-carboxy-5-chloropyridyl 3-deoxy-3-[4-(2-hydroxyt...)
Affinity DataKd:  46nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-3(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508749(2-carboxy-5-chloropyridyl 3-deoxy-3-[4-(2-hydroxyt...)
Affinity DataKd:  5.70E+3nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-1(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508750(5-Bromo-6-trifluoromethyl-pyridine-3-yl 3-deoxy-3-...)
Affinity DataKd:  390nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-3(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508750(5-Bromo-6-trifluoromethyl-pyridine-3-yl 3-deoxy-3-...)
Affinity DataKd:  69nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-1(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508751(3,4-Dichloro-6-fluoro-phenyl 3-deoxy-3-[4-(2-hydro...)
Affinity DataKd:  13nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-3(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508751(3,4-Dichloro-6-fluoro-phenyl 3-deoxy-3-[4-(2-hydro...)
Affinity DataKd:  4.60E+3nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-1(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508752(4-Chloro-N,N′-dimethylbenzamide-2-yl 3-deoxy...)
Affinity DataKd:  44nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGalectin-3(Homo sapiens (Human))
Galecto Biotech

US Patent
LigandPNGBDBM508752(4-Chloro-N,N′-dimethylbenzamide-2-yl 3-deoxy...)
Affinity DataKd:  2.10E+3nMAssay Description:The affinity of Example 1-33 for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the inte...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 52 total ) | Next | Last >>
Jump to: